Histopathological re-examination of prostate gland biopsy

Histopathological re-examination of prostate gland biopsy is essential element of prostate cancer diagnostic process. Unfortunately, in Poland availability of pathologists who specialize in the evaluation of biopsies obtained from the prostate is very limited and often result in incorrect or incomplete histopathological assessment. International scientific literature shows that even 20% of samples which already have Gleason score is evaluated differently after histopathological re-examination conducted by a histopathologist specialised in prostate cancer diagnostics.

Histopathological examination of prostate gland biopsy

Histopathological examination of prostate gland biopsy because of prostate cancer's characteristics (multifocal and limited volume of tissue) is regarded as one of the hardest to perform. The result of this examination is essential for further treatment and this is why HIFU Clinic Prostate Cancer Treatment Centre offers the possibility of re-examination of prostate gland biopsy conducted by the qualified histopathologist.

If patient has Gleason score 4(2+2) re-examination is nessesary, because in current prostate cancer diagnostics this score is not correct. Due to the clinical consequences of Gleason 5(2+3), Gleason 5(3+2), Gleason 6(3+3), Gleason 7(3+4) and Gleason 7(4+3) scores re-examination is also recommended. Histopathological re-examination of prostate gland biopsy often leads to the selection of less invasive treatment, which means shorter recovery time and lower risk of complications. In addition, in some cases, it enables safe and close observation.

Histopathological examination conducted by HIFU Clinic Prostate Cancer Treatment Centre specialists is in line with all international guidelines. It contains full particulars required to appropriate choice of treatment method. Histopathological report made in our clinic contains data concerning: number, location and length of the examined samples; the percentage of biopsies taken by cancer and data concerning cancer's invasion on surrounding nerve and vascular structures.

For more information about histopathological re-examination and the procedure for obtaining samples from diagnostic laboratory please call 512 077 461 or write at kontakt@hifu.pl.